Lipopolysaccharide (LPS) and Toll‐like receptor 4 (TLR4) are significantly increased during the progression of nonalcoholic fatty liver disease (NAFLD). Here, TLR4 is linked to metabolic dysfunction-associated steatotic liver disease.